Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome

R. Robbins, R. Maunder, G. Gossman, T. Kendall, L. Hudson, Stephen Israel Rennard

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The adult respiratory distress syndrome (ARDS) is often characterized by a neutrophilic alveolitis, which may be mediated in part by the neutrophil chemoattractant, C5a. Chemotactic factor inactivator (CFI) can decrease C5a-directed neutrophil chemotaxis. Thus, a loss of CFI activity in the ARDS lung could lead to an increased ability of C5a to attract neutrophils. Lung CFI levels were measured antigenically and functionally in bronchoalveolar lavage (BAL) fluid obtained from 29 patients with ARDS and in 14 normal control subjets. Antigenic levels of CFI were found to be markedly elevated in ARDS BAL fluid (1,855 ± 437 ng/ml) compared with that in normal BAL (29 ± 10 ng/ml, p<0.005), but, in contrast, CFI functional activity was markedly decreased in ARDS BAL fluid compared with that in normal BAL fluid (31 ± 7% inhibition versus 76 ± 5% inhibition, p<0.01). Furthermore, although purified CFI readily inhibited the ability of C5a to attract neutrophils (92% inhibition), this activity was decreased when BAL fluid from patients with ARDS was incubated with CFI (47 ± 10%, p<0.01). These findings suggest that patients with ARDS are functionally deficient in CFI, leading to an increased ability of C5a to attract neutrophils.

Original languageEnglish (US)
Pages (from-to)1463-1468
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume141
Issue number6
DOIs
StatePublished - Jan 1 1990

Fingerprint

Adult Respiratory Distress Syndrome
Bronchoalveolar Lavage Fluid
Neutrophils
Aptitude
Lung
chemotactic factor inactivator
Chemotactic Factors
Bronchoalveolar Lavage
Chemotaxis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome. / Robbins, R.; Maunder, R.; Gossman, G.; Kendall, T.; Hudson, L.; Rennard, Stephen Israel.

In: American Review of Respiratory Disease, Vol. 141, No. 6, 01.01.1990, p. 1463-1468.

Research output: Contribution to journalArticle

Robbins, R, Maunder, R, Gossman, G, Kendall, T, Hudson, L & Rennard, SI 1990, 'Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome', American Review of Respiratory Disease, vol. 141, no. 6, pp. 1463-1468. https://doi.org/10.1164/ajrccm/141.6.1463
Robbins, R. ; Maunder, R. ; Gossman, G. ; Kendall, T. ; Hudson, L. ; Rennard, Stephen Israel. / Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome. In: American Review of Respiratory Disease. 1990 ; Vol. 141, No. 6. pp. 1463-1468.
@article{750a6242bce549dcbc5a2947d2ecf422,
title = "Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome",
abstract = "The adult respiratory distress syndrome (ARDS) is often characterized by a neutrophilic alveolitis, which may be mediated in part by the neutrophil chemoattractant, C5a. Chemotactic factor inactivator (CFI) can decrease C5a-directed neutrophil chemotaxis. Thus, a loss of CFI activity in the ARDS lung could lead to an increased ability of C5a to attract neutrophils. Lung CFI levels were measured antigenically and functionally in bronchoalveolar lavage (BAL) fluid obtained from 29 patients with ARDS and in 14 normal control subjets. Antigenic levels of CFI were found to be markedly elevated in ARDS BAL fluid (1,855 ± 437 ng/ml) compared with that in normal BAL (29 ± 10 ng/ml, p<0.005), but, in contrast, CFI functional activity was markedly decreased in ARDS BAL fluid compared with that in normal BAL fluid (31 ± 7{\%} inhibition versus 76 ± 5{\%} inhibition, p<0.01). Furthermore, although purified CFI readily inhibited the ability of C5a to attract neutrophils (92{\%} inhibition), this activity was decreased when BAL fluid from patients with ARDS was incubated with CFI (47 ± 10{\%}, p<0.01). These findings suggest that patients with ARDS are functionally deficient in CFI, leading to an increased ability of C5a to attract neutrophils.",
author = "R. Robbins and R. Maunder and G. Gossman and T. Kendall and L. Hudson and Rennard, {Stephen Israel}",
year = "1990",
month = "1",
day = "1",
doi = "10.1164/ajrccm/141.6.1463",
language = "English (US)",
volume = "141",
pages = "1463--1468",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome

AU - Robbins, R.

AU - Maunder, R.

AU - Gossman, G.

AU - Kendall, T.

AU - Hudson, L.

AU - Rennard, Stephen Israel

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The adult respiratory distress syndrome (ARDS) is often characterized by a neutrophilic alveolitis, which may be mediated in part by the neutrophil chemoattractant, C5a. Chemotactic factor inactivator (CFI) can decrease C5a-directed neutrophil chemotaxis. Thus, a loss of CFI activity in the ARDS lung could lead to an increased ability of C5a to attract neutrophils. Lung CFI levels were measured antigenically and functionally in bronchoalveolar lavage (BAL) fluid obtained from 29 patients with ARDS and in 14 normal control subjets. Antigenic levels of CFI were found to be markedly elevated in ARDS BAL fluid (1,855 ± 437 ng/ml) compared with that in normal BAL (29 ± 10 ng/ml, p<0.005), but, in contrast, CFI functional activity was markedly decreased in ARDS BAL fluid compared with that in normal BAL fluid (31 ± 7% inhibition versus 76 ± 5% inhibition, p<0.01). Furthermore, although purified CFI readily inhibited the ability of C5a to attract neutrophils (92% inhibition), this activity was decreased when BAL fluid from patients with ARDS was incubated with CFI (47 ± 10%, p<0.01). These findings suggest that patients with ARDS are functionally deficient in CFI, leading to an increased ability of C5a to attract neutrophils.

AB - The adult respiratory distress syndrome (ARDS) is often characterized by a neutrophilic alveolitis, which may be mediated in part by the neutrophil chemoattractant, C5a. Chemotactic factor inactivator (CFI) can decrease C5a-directed neutrophil chemotaxis. Thus, a loss of CFI activity in the ARDS lung could lead to an increased ability of C5a to attract neutrophils. Lung CFI levels were measured antigenically and functionally in bronchoalveolar lavage (BAL) fluid obtained from 29 patients with ARDS and in 14 normal control subjets. Antigenic levels of CFI were found to be markedly elevated in ARDS BAL fluid (1,855 ± 437 ng/ml) compared with that in normal BAL (29 ± 10 ng/ml, p<0.005), but, in contrast, CFI functional activity was markedly decreased in ARDS BAL fluid compared with that in normal BAL fluid (31 ± 7% inhibition versus 76 ± 5% inhibition, p<0.01). Furthermore, although purified CFI readily inhibited the ability of C5a to attract neutrophils (92% inhibition), this activity was decreased when BAL fluid from patients with ARDS was incubated with CFI (47 ± 10%, p<0.01). These findings suggest that patients with ARDS are functionally deficient in CFI, leading to an increased ability of C5a to attract neutrophils.

UR - http://www.scopus.com/inward/record.url?scp=0025367831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025367831&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/141.6.1463

DO - 10.1164/ajrccm/141.6.1463

M3 - Article

VL - 141

SP - 1463

EP - 1468

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -